PB2136: PLANNED-USE GLUCARPIDASE FOR OUTPATIENT HIGH DOSE METHOTREXATE (HD-MTX) ADMINISTRATION IN PATIENTS WITH CNS LYMPHOMA (CNSL) DURING THE COVID-19 PANDEMIC

PB2136: PLANNED-USE GLUCARPIDASE FOR OUTPATIENT HIGH DOSE METHOTREXATE (HD-MTX) ADMINISTRATION IN PATIENTS WITH CNS LYMPHOMA (CNSL) DURING THE COVID-19 PANDEMIC

Bibliographic Details
Main Authors:	L. Schaff, M. Lobbous, D. Carlow, L. DeAngelis, L. B. Nabors, C. Grommes
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000851376.34315.4f

Similar Items

Routine use of low-dose glucarpidase following high-dose methotrexate in adult patients with CNS lymphoma: an open-label, multi-center phase I study
by: Lauren R. Schaff, et al.
Published: (2022-01-01)

Implementation of an Outpatient HD-MTX Initiative
by: Kelsey Sokol, et al.
Published: (2022-01-01)

PB2106: REDUCTION OF METHOTREXATE (MTX) LEVELS AFTER GLUCARPIDASE IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) AT RISK OF CENTRAL NERVOUS SYSTEM (CNS) INVOLVEMENT WHO RECEIVE HDMTX: PHASE 2
by: A. De La Fuente, et al.
Published: (2022-06-01)

2136
by: Muna Qayed, et al.
Published: (2017-09-01)

Relationship Between the Free and Total Methotrexate Plasma Concentration in Children and Application to Predict the Toxicity of HD-MTX
by: Wei-Chong Dong, et al.
Published: (2021-04-01)

Treatment of methotrexate (MTX) intolerance: behavioural therapy, versus switch to parenteral MTX versus oral MTX
by: Wulffraat NM, et al.
Published: (2011-09-01)

Recovery of methotrexate-induced anuric acute kidney injury after glucarpidase therapy
by: James Harms, et al.
Published: (2017-04-01)

Update on Novel Therapeutics for Primary CNS Lymphoma
by: Lauren R. Schaff, et al.
Published: (2021-10-01)

Methotrexate (MTX) Plus Hydroxychloroquine versus MTX Plus Leflunomide in Patients with MTX-Resistant Active Rheumatoid Arthritis: A 2-Year Cohort Study in Real World
by: Zhang L, et al.
Published: (2020-12-01)

Methotrexate (MTX) failed to control giant cell arteritis (GCA)
by: Hoffman, G, et al.
Published: (2001)

Glucarpidase for Treating Adults with Delayed Methotrexate Elimination Due to Impaired Renal Function: An Economic Simulation Analysis
by: Kala J, et al.
Published: (2023-03-01)

Predictors and clinical features of methotrexate (MTX) therapy for ectopic pregnancy
by: Jing Zhang, et al.
Published: (2020-10-01)

How to get the most from methotrexate (MTX) treatment for your rheumatoid arthritis patient?—MTX in the treat-to-target strategy
by: Taylor, P, et al.
Published: (2019)

International Survey to Evaluate Current Options for Subcutaneous Injection of Methotrexate (MTX) and a New Button-Free MTX Autoinjector
by: Müller-Ladner U, et al.
Published: (2024-03-01)

Development of a population pharmacokinetics and pharmacodynamics model of glucarpidase rescue treatment after high-dose methotrexate therapy
by: Yutaka Fukaya, et al.
Published: (2023-01-01)

2136 Frequently overlooked challenges of pragmatic trials
by: Rodger S. Kessler
Published: (2018-06-01)

Glucarpidase (carboxypeptidase G2): Biotechnological production, clinical application as a methotrexate antidote, and placement in targeted cancer therapy
by: Fatemeh Moradbeygi, et al.
Published: (2023-10-01)

A multicenter placebo-controlled study of methotrexate (MTX) in giant cell arteritis (GCA).
by: Hoffman, G, et al.
Published: (2000)

P1135: EFFECT OF GLUCARPIDASE RESCUE IN PATIENTS WITH HIGH-DOSE METHOTREXATE INDUCED ACUTE KIDNEY INJURY: A FRENCH PHARMACOVIGILANCE DATABASE STUDY
by: Sabrina Pierre, et al.
Published: (2023-08-01)

Effect of the antirheumatic medication methotrexate (MTX) on biomechanical compressed human periodontal ligament fibroblasts (hPDLFs)
by: Claudia Welte-Jzyk, et al.
Published: (2024-03-01)

PB2136: THE VALUE OF PERIPHERAL BLOOD LYMPHOCYTE SUBSETS IN PREDICTING THE PROGNOSIS OF NEWLY DIAGNOSED MULTIPLE MYELOMA
by: Zhaoyun Liu, et al.
Published: (2023-08-01)

Effects of cashew nut shell liquid (CNSL) on the performance of broiler chickens
by: C.A.A. López, et al.
Published: (2012-08-01)

Effects of aqueous extract of catechin tea on some parameters of sperms and histopathological changes in testis of mice treated with Methotrexate (MTX)
by: Abbas Fadhil Daham, et al.
Published: (2010-12-01)

Facile Electrochemical Determination of Methotrexate (MTX) Using Glassy Carbon Electrode-Modified with Electronically Disordered NiO Nanostructures
by: Aftab A. Khand, et al.
Published: (2021-05-01)

Identification and characterization of the direct interaction between methotrexate (MTX) and high-mobility group box 1 (HMGB1) protein.
by: Yuki Kuroiwa, et al.
Published: (2013-01-01)

A note on the potential of CNSL in fuel blends for engines in Brazil
by: Fernando José Araújo da Silva
Published: (2016-06-01)

Nucleotide binding as an allosteric regulatory mechanism for Akkermansia muciniphila β-N-acetylhexosaminidase Am2136
by: Chang-Cheng Li, et al.
Published: (2022-12-01)

TESS discovery of a sub-Neptune orbiting a mid-M dwarf TOI-2136
by: De Wit, Julian, et al.
Published: (2023)

Investigating which variables from the core outcome variables in juvenile idiopathic arthritis (JIA) are the best predictors of classification as a responder to treatment with methotrexate (MTX)
by: Hirani SP, et al.
Published: (2008-09-01)

Filgotinib (GLPG0634/GS-6034), an oral JAK1 selective inhibitor, is effective in combination with methotrexate (MTX) in patients with active rheumatoid arthritis and insufficient response to MTX: results from a randomised, dose-finding study
by: Westhovens, R, et al.
Published: (2016)

Studies on use of Cashew Nut Shell Liquid (CNSL) in Biopesticide and Biofertilizer
by: C. Vasanth Pandiyan, Gunasekaran Shylaja, Gokul Raghavendra Srinivasan and Sujatha Saravanan
Published: (2020-03-01)

Cashew Nut Shell Liquid (CNSL) as a Source of Drugs for Alzheimer’s Disease
by: Elisa Uliassi, et al.
Published: (2021-09-01)

Efficacy assessment of oxygen flow assisted administration of topical methotrexate (OFA‐MTX5%) for superficial basal cell carcinoma assessed by optical coherence tomography
by: Gilles Absil, et al.
Published: (2023-03-01)

Use of glucarpidase (carboxypeptidase‐G2) in pediatric cancer patients: 11‐year experience of a tertiary center
by: Rocío Vila, et al.
Published: (2023-11-01)

Development of Sustainable Chemistry in Madagascar: Example of the Valuation of CNSL and the Use of Chromones as an Attractant for Mosquitoes
by: Miarintsoa Michaele Ranarijaona, et al.
Published: (2021-12-01)

EFFECT OF CASHEW NUT SHELL LIQUID (CNSL) ON TRIBOLOGICAL BEHAVIOR OF BRAKE PAD COMPOSITE
by: Harun YANAR, et al.
Published: (2019-06-01)

A Delphi study to determine the epidemiology and clinical management of patients treated with HDMTX who develop methotrexate (MTX) delayed elimination in France, Germany, Italy, and the UK
by: Stefan Bielack, et al.
Published: (2024-01-01)

Comparison of Benefits and Risks Associated with Anti-T-Lymphocyte Globulin (ATLG) Serotherapy in Methotrexate (MTX)- versus Mycophenolate Mofetil (MMF)-Based Hematopoietic Stem Cell Transplantation
by: Alexander Nikoloudis, et al.
Published: (2023-02-01)

P1202: INTENDED USE OF GLUCARPIDASE IN PATIENTS WITH CENTRAL NERVOUS SYSTEM LYMPHOMA AND IMPAIRED RENAL FUNCTION – THE VALIDATE STUDY
by: S. Liebig, et al.
Published: (2022-06-01)

Potential toxicity of cashew nut shell liquid (CNSL) on adult Bactrocera dorsalis (Hendel) (Tephritidae)
by: Sainey Keita, et al.
Published: (2023-12-01)